Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral N-acetylcysteine in hemodialysis patients with elevated CRP
IRCT2016111030821N1Phase 4Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of acetylcysteine in end-stage kidney disease (ESKD), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Serum high-sensitivity C-reactive protein and Hemoglobin. Started Oct 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT2016111030821N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016111030821N1.